News

  • 19 January 2012

    Adeona begins Phase II study of multiple sclerosis drug

    Adeona Pharmaceuticals, a developer of synthetic DNA-based therapeutics, has commenced the Phase II clinical trial of its Trimesta drug, designed to treat cognitive dysfunction in multiple sclerosis (MS).

  • 18 January 2012

    Media-Soft develops new pharma CRM solution

    Media-Soft, a pharmacentric company, has developed new flagship product Sales Vision Android, an offline / online Android-based pharma CRM and SFE tool for pharmaceuticals.

  • 15 January 2012

    NovAliX and Teijin Pharma strike drug discovery alliance

    NovAliX SAS has entered into a multitarget integrated drug discovery collaboration with Tokyo-based Teijin Pharma to develop novel drug candidates against multiple targets across different therapeutic areas.

Go Top